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ABSTRACT
Aim: MicroRNAs (miR) are important diagnostic and treatment targets due to their different tissue
expressions and their central position in the regulation of gene expressions. miR studies might
pioneer emerging of new diagnostic tools and treatment goals in kidney diseases. Captopril
(CAP) and telmisartan (TEL) were shown to be effective in ischemia reperfusion (IR) injury. There
is not any study about the effect of TEL and CAP over miR-21-320-146a. Our aim was to study
the effects of CAP and TEL over miR on renal IR model.
Methods: We used 12–16 weeks-old Wistar-Albino rats that weigh 300–350 g. Rats (n, 6) were
randomized into four groups (Control, IR, IRþCAP, IRþ TEL). Urea, creatinine, total antioxidant
status (TAS), total oxidant status (TOS), oxidative stress index (OSI), super oxide dismutase (SOD),
and miRs were analyzed.
Results: Urea, creatinine, TOS, OSI levels of IRþCAP, and IRþ TEL groups were lower comparing
to IR group. TAS and SOD levels were higher in IR group than IRþ TEL group. miR-21-320-146a
showed increase in renal IR injury. miR-320, 146a showed significant decrease in IRþCAP and
IRþ TEL groups comparing to IR group. We showed histopathological recovery and decreased
apoptosis in IRþCAP and IRþ T groups than IR group.
Conclusion: We, for the first time in the literature, showed that miR-320 is increased in IR injury.
miR-320 might be a novel diagnosis and treatment target in renal ischemic reperfusion injury.
Also, for the first time, we showed that CAP and TEL cause functional and histopathological
recovery and lower miR-146a and miR-320.
ARTICLE HISTORY
Received 17 April 2016
Revised 20 July 2016
Accepted 18 August 2016









Acute renal failure (ARF) is a frequently encountered
problem in clinical nephrology and has a high mortality
rate.1 It is also one of the main causes of permanent
and progressive kidney failure and it also increases
acute mortality rate.2 Ischemia reperfusion (IR) injury is
the central event in ARF. Even with progresses in diag-
nosis and treatment methods, ischemic ARF is a major
and common clinical problem.3
MicroRNAs (miR) are type of single-stranded RNA
molecule, approximately 21–23 nucleotide long and
have vital role in the regulation of gene expression.
Tissue expression differences of miRs and their central
role on regulation of gene expressions make them an
important target on diagnosis and treatment of dis-
eases. Recently, researchers showed that miRs have
an important role in prognosis of kidney diseases.4
miR studies might pioneer the emergence of novel
diagnostic tools and treatment targets in kidney
diseases.
miR-21 and miR-146a were shown to have a role in
renal IR injury.5,6 It was also shown that miR-320 is upre-
gulated in gentamicin toxicity of kidney.7 We hypostat-
ized that miR-320 might be a potential biomarker in
ischemic ARF because miRs are specific to tissues.
Angiotensin II (A2) and renin–angiotensin–aldoster-
one system (RAAS) might impair kidney functions by
increasing systemic vascular resistance and inflamma-
tory process. Several studies showed that angiotensin
activity or inhibition of A2 products prevent renal injury
in case of ischemic ARF.8,9 Captopril (CAP) is an angio-
tensin-converting enzyme (ACE)-inhibitor. It lowers A2
level in circulation. CAP has a potent antioxidant feature
due to the presence of thiol compound. It aggregates
different types of reactive oxygen radicals and prevents
lipid peroxidation.10,11 It has been shown that CAP is
preventive against tissue damage induced by oxidative
CONTACT Aydın G€uçl€u, MD aydinguclu@gmail.com Department of Nephrology, Faculty of Medicine, Ahi Evran University, Kırşehir, Turkey
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stress and inflammation in various experimental
models.12,13
Telmisartan (TEL) is a highly-selective angiotensin I
(AT1) receptor blocker. Protective role of TEL was shown
in rat models of nephrectomy,14 cyclosporine-induced
nephrotoxicity,15 and IR.16 Also, TEL has antioxidant and
anti-inflammatory effect independently of AT1 receptor
blockage17,18. CAP and TEL were shown to be effective
in IR injury. However, the mechanism of action is
unknown.
There is no reported study that shows the effect of
CAP and TEL on miR-21, -320 and -146a. Our aim was to
evaluate the effect of CAP and TEL on miRs in renal IR
model.
Materials and methods
This study was done in accordance with the Care and
Use of Laboratory Animals published by the Institute of
Laboratory Animal Resources Commission on Life
Sciences National Research Council after obtaining local
ethics committee approval (date 04 January 2016,
approval number: 2016.01.05).
Animals
We used 12–16 weeks old Wistar-Albino male rats that
weigh 300–350 g for the study. Six rats were random-
ized to each group. All rats were kept in transparent
polycarbonate cages, where they can reach fresh water
and food, under 12 h of darkness and light cycles.
Chemicals
Both CAP and TEL were obtained from Santa Cruz
Biotechnology (Santa Cruz Biotechnology, Santa Cruz,
CA). CAP was dissolved in sterile saline. Tween-80 was
bought from Merck Corporation (Merck, Darmstadt,
Germany). TEL was dissolved in 1% Tween-80 in sterile
saline.19 All chemicals were freshly prepared just before
being used in the experiment.20,21
Experimental study design
Study animals were stratified into four groups by ran-
domization (n, 6); Group C: all animals were subjected
to laparotomy without IR; Group IR: rats were subjected
to 60min of ischemia followed by 120min of reperfu-
sion; Group IRþCAP: Rats were subjected to 60min of
ischemia followed by 120min of reperfusion, 1ml of
50mg/kg CAP was administered 2 h before IR by oral
gavage; Group IRþ TEL: Rats were subjected to 60min
of ischemia followed by 120min of reperfusion, 1mL of
3mg/kg TEL was administered 3 h before IR by oral
gavage.20,21
Surgical procedures
Rats were anesthetized by 10mg/kg xylazine hydrochlor-
ide (Rompun, Bayer, Istanbul, Turkey) and 70mg/kg keta-
mine (Ketalar, Pfizer, Istanbul, Turkey). After administering
enough anesthesia, abdominal walls of rats were shaved
and sterilized with povidone iodine on homoeothermic
table to keep body temperature stabile at 37.1 C. Midline
incision was applied and right and left renal arteries and
veins were revealed. Both renal peduncles were clamped
for 60min with atraumatic vascular clamp (Vascu Stop
Bulldog Clamp, Istanbul, Turkey). Clamps were loosening
after 60min of ischemia. Hundred and twentyminutes of
reperfusion was allowed. After 120min, blood samples




sue samples were washed with cold-heparinized phos-





Preparation of renal tissue homogenates: renal tissue
was mixed with cold study solution (50mmol/L phos-
phate buffer, pH 7.40) and centrifuged at 10,000 g for
15min atþ4 C after homogenization using a mechanic
homogenizer.
Measurement of serum urea and creatinine values
Serum urea and creatinine values were measured using
Beckman Coulter AU680 analyzer (Beckman
Coulter, Miami, FL). Serum urea values were expressed
as mg/dL.
Measurement of tissue TAS, TOS and OSI values
Tissue total antioxidant status (TAS) and total oxidant
status (TOS) values were measured with Beckman
Coulter AU680 analyzer (Beckman Coulter) using com-
mercial reagents (Rel Assay Diagnostic, Gaziantep,
Turkey).22 TAS values were expressed as TroloxEq/mg
protein. TOS values were expressed as lmolH2O2 Eq/mg
protein. Oxidative stress index (OSI) was measured as
percentage ratio of TOS level to TAS level after mmol
value of TAS test unit was converted to lmol as in TOS
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test.23 Tissue super oxide dismutase (SOD) activities
were measured on a Beckman Coulter AU680 analyzer
(Beckman Coulter) using the Ransod kit (Randox
Laboratories, Crumlin, UK). SOD activities were
expressed as U/mg of protein.
miR analysis
Total RNA isolation and real-time PCR
The kidney was sectionalized into smaller pieces using a
lancet on ice in trizol solution. We isolated total RNA
from kidney tissues of rats of all groups with TRIzol
reagent (Invitrogen Thermo Scientific, Waltham, MA)
according to the manufacturer’s protocol and quanti-
tated with a NanodropTM spectrophotometer (Thermo
Scientific). miR cDNA was synthesized by TaqManVR
MicroRNA Reverse Transcription kit according to man-
ufacturer’s procedure (ThermoFischer Scientific). We
used Step One real-time PCR with miR-21- and
miR146a-specific primers to evaluate the miR expres-
sion. Analysis of relative quantification of miR-320, miR-
21, and miR-146a were done with RT-PCR using
TaqManVR Universal Master Mix II, noUNG, miR qPCR
profiling kits. U6 was used as rat endogenous controls.
Histopathological examinations
Renal tissue samples were embedded into paraffin
blocks after fixation using 10% formalin. Paraffin blocks
were sectioned (4 lm) and stained with hematoxylin
eosin. All samples were evaluated by a pathologist who
was blind to all study groups with a light microscope
(BX51; Olympus, Tokyo, Japan). The Jablonski grading
scale (0–4) was used for the assessment of I-R-induced
study groups.24
In situ tunnel was used to evaluate renal apoptosis.
Formalin-fixated sections were deparaffinized in xylene
and rehydrated in graded concentrations of ethanol in
water. Apoptotic DNA fragmentations were identified
with commercial kit (ApopTag Peroxidase In Situ
Apoptosis Detection Kit, Milli pore, Billerica, MA)
according to the manufacturer’s protocol. Sections were
examined using a light microscope (Olympus BX51,
Olympus Optical, Tokyo, Japan). We counted tunnel
positive cells among 100 cells in randomly chosen areas.
Apoptotic index was measured as percentage of apop-
totic cell.
Statistical analysis
We used DDCT method to analyze the miR expression
and quantified with a computer program. Groups were
compared with “Volcano Plot” analysis. Volcano plot
analysis is a part of “RT2 Profiles TMPCR Array Data
Analysis” and uses “Student’s t-test” for statistical ana-
lysis. Spike frequency and amplitude values were meas-
ured with repeated measures analysis of variance
(ANOVA) and post hoc Tukey’s test. The spike frequency
and amplitude values of different dose groups were
compared using one-way ANOVA and post hoc Tukey’s
tests. p< .05 was considered significant.
Results
Mean urea and creatinine values of IRþCAP and
IRþ TEL groups were significantly lower comparing to
IR group (<.001). Urea and creatinine values were not
significantly different between IRþCAP and IRþ TEL
groups. TAS was significantly higher in IRþ TEL group
than IR group, while it showed a trend to statistical sig-
nificance in IRþCAP group comparing to IR group. We
identified significant decrease of OSI in IRþCAP and
IRþ TEL groups comparing to IR group (p¼ .001).
However, no difference was identified between OSI
IRþCAP and IRþ TEL. We identified a significant
increase of TAS in IRþCAP and IRþ TEL groups com-
paring to IR group (p< .001) (Table 1).
miR 320 showed significant increase in IR group
comparing to rat endogenous. miR-320 was significantly
decreased in IRþCAP and IRþ TEL groups than IR
group (p< .05). miR-21 showed a significant increase in
IR group (p¼ .01), in IRþCAP group, in IRþ TEL group
Table 1. Comparison of biochemical and histological data among experimental groups.
Control (mean± SD) IR (mean ± SD) IRþ CAP (mean ± SD) IRþ T (mean± SD)
Urea(mg/dl) 48.50 ± 5.82 86.33 ± 6.65 73.33 ± 3.07,a 67.66 ± 1.86,a
Creatinin(mg/dl) 0.36 ± 0.03 0.63 ± 0.03 0.54 ± 0.03,a 0.50 ± 0.04,a
TAS (Trolox Eq/mg protein) 1.85 ± 0.11 1.29 ± 0.22 1.61 ± 0.31 1.72 ± 0.130
TOS (H2O2 Eq/mg protein) 2.99 ± 0.43 10.19 ± 2.95 4.10 ± 1.38a 3.75 ± 0.14a
OSI (Arbitrary Unit) 0.22 ± 0.08 0.93 ± 0.16 0.58 ± 0.21,a 0.37 ± 0.06a
SOD U/mg protein 7.38 ± 0.31 3.93 ± 1.36 5.93 ± 0.53,a 6.34 ± 0.39a
p< .001 versus control.
ap< .001 versus IR Group.
TAS: Total Antioksidan Status; TOS: Total Oksidan Status; OS_I: Oxidative Stress _Index; SOD: super oxide dismutase; IR: ische-
mia-reperfusion group; IRþ CAP: captoprilþ ischemia-reperfusion group; IRþ TEL: telmisartanþ ischemia-reperfusion group.
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comparing to endogenous rat controls (p< .05). miR-21
didn’t show any significant difference in IRþCAP and
IRþ TEL groups comparing to IR group. miR-146a was
significantly increased in IR group (p¼ .01), in IRþCAP
group (p¼ .027), in IRþ TEL group comparing to
endogenous rat controls. miR-146a was significantly
decreased in IRþCAP and IRþ TEL groups than IR
group (p< .05) (Figure 1).
Histopathological evaluation
We observed significant degeneration in tubular struc-
ture, necrosis in proximal convoluted tubule, loss of
brush border and nuclei and mild capillary congestion
in glomerulus (Figure 2) in IR group. In CAP and TEL
groups, we also observed mild cellular necrosis and
tubular dilatation and recovery of most of the morpho-
logical changes which were observed in IR group. Renal
injury score was significantly lower in IRþCAP and
IRþ TEL groups comparing to IR group (p< .01).
We didn’t find any significant difference between
IRþCAP and IRþ TEL groups in terms of renal damage
scores.
Evaluation with tunnel method
TUNELþ cell count was increased in IR group compar-
ing to control group. TUNELþ cell count was signifi-
cantly lower in IRþCAP and IRþ T groups comparing
to IR group. Apoptosis scores were significantly
increased in IR group than control group (p< .01).
Apoptosis scores of IRþCAP and IRþ T groups were
significantly lower than IR group (p< .01). There was no
significant difference between IRþCAP and IRþ T
groups (Figure 3).
Discussion
Kidney tissue, especially renal tubule, is sensitive to hyp-
oxic ischemic injury due to its demand for high energy.
Importance of miR-21 in IR injury grew recently. In
accordance with our study, Godwin et al.6 and Wei
et al.25 also observed that miR-21 increases in IR. It has
been shown that miR-21 has an important role in myo-
cardial IR injury.26,27 Mechanism of IR injury is quite
complex; on the other hand, a substantial part of dam-
age is related to reactive oxygen radicals during reper-
fusion.28 In accordance with previous studies, we
showed that TOS and OSI activities, which are indicators
of reactive oxygen radicals, were significantly increased
in IR group. It has been shown that Hif-1 alpha increases
with increase in ROS, while miR-21 activation also
increases with HIF-1 alpha.29,30 miR-21 increase in our
study might be caused by the increase in HIF-1 alpha
which is due to ROS increase.
In our study, for the first time, we showed that miR-
320 increases in IR injury. Lorenzen et al. showed that
miR-320 downregulates in critically ill patients with ARF
who were admitted to the intensive care unit.31
However, common factors seen in intensive care unit
patients such as infection, frequent drug administration
and comorbidities might affect miR levels, but we
excluded these factors in our study and showed that
miR-320 significantly increases in renal IR injury. Cell-
and tissue-specific expressions are the major character-
istics of the miR expression. Identification of miR-320
Figure 1. The comparison among groups of microRNA levels.
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upregulation in renal tubular injury caused by gentami-
cin toxicity (7) revealed the importance of miR-320 in
renal tissues. Increases in cell death and apoptosis due
to miR-320 overexpression were shown in invitro study.
Also, larger myocardial infarction areas were identified
in transgenic rats with miR-320 overexpression after IR.
In addition to this, infarction area was decreased after
inhibition of miR-320.32 These studies are in accordance
with the role of miR-320 in IR injury and apoptosis. We
also found that apoptosis was significantly higher in IR
Figure 2. Representative histological photographs of PAS-stained kidney tissue in the experimental groups. (a) Control group, (b)
ischemia-reperfusion group, (c) captoprilþ ischemia-reperfusion group, (d) telmisartanþ ischemia-reperfusion group, (e) hematoxy-
lin and eosin staining (H&E 9 100) showed that there was no change in control rats. (IR) IR: ischemia-reperfusion group, IRþ CAP:
captoprilþ ischemia-reperfusion group, IRþ TEL: telmisartanþ ischemia-reperfusion group. The “BL” denotes brush border loss,
“H” denotes hemorrhage, and “NL” denotes nuclei loss. In IRþ CAP and IRþ TEL groups, we also observed mild cellular necrosis
and tubular dilatation and recovery of most of the morphological changes which were observed in IR group. p shows the differ-
ences between all groups (one-way ANOVA test). < .001, compared to the control group; a< .001, compared to the IR group
(post hoc Tukey’s test).
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group, which had significantly higher levels of miR-320.
In our study, we identified decreases in apoptosis and
miR-320 levels due to CAP and TEL treatment. This find-
ing supports the relation between miR-320 and apop-
tosis. MiR-320 was shown to inhibit Hsp20 expression.
Increased Hsp20 expression was shown to be protective
and to lower apoptosis rate against IR injury in
neuroblastoma cells.33 In our study, higher levels of
miR-320 in IR group might have increased renal injury
and apoptosis rate by decreasing HSP20.
In accordance with our study, it has been shown that
miR-146a increases in renal IR injury.6 Also, miR-146a
had shown to be upregulated by ROS-producing metal
sulfates in human astroglial cells.34 These studies prove
Figure 3. Examination of tunelþ cells in kidney tissues in the experimental groups. The positive TUNEL reaction is visible as a
dark brown apoptosis in control rats. (a) control group, (b) ischemia-reperfusion group, (c) captoprilþ ischemia-reperfusion group,
(d) telmisartanþ ischemia-reperfusion group. Significant positive cell count was identified in IR injury comparing to control.
TUNELþ cell count was increased in IR group comparing to control group. TUNELþ cell count was significantly lower in IRþ CAP
and IRþ TEL groups comparing to IR group. p shows the differences between all groups (one-way ANOVA test). <.001, com-
pared to the control group; a<.001, compared to the IR group (post hoc Tukey’s test).
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that ROS increase is closely related to miR-146a
increase. In our study, miR-146a might be increased due
to ROS increase in IR injury. Also, it has been shown
that increased miR-146a downregulates SOD.35 In
accordance with the literature, we observed an
increased miR-146a and a decreased SOD activity in our
study.
In line with our study, it has been shown that CAP
and TEL were protective against IR injury.20,36,37
However, its mechanism of action cannot be explained
clearly. MiR-146a was decreased in TEL and CAP treat-
ment groups in our study. MiR-146a lowering effect of
CAP and TEL treatment might be due to their lowering
effect on NF-jB activity. It has been shown that TEL and
CAP treatments inhibit NF-jB.38,39 Also, NF-jB activity
increases miR-146 gene transcription.34
In conclusion, we, for the first time, showed that
miR-320 increases in IR injury. MiR-320 might be a novel
diagnostic and therapeutic target in renal IR injury. Also,
we for the first time showed that CAP and TEL therapies
decrease miR-146a and -320. Recovery effects of CAP
and TEL in renal IR injury might be over miR-146a and
miR-320.
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